While modified nucleic acids hold great promise in genomic applications, it will be difficult to use them effectively until their biophysical properties are known, and moreover, until they are integrated into efficient assay-design software. Celadon's research aims to discover accurate and predictive design rules for a series of potentially effective modified nucleic acid chemistries, and to incorporate these design rules into its predictive software platform, ProbeITy.